IC Biomedical

IC Biomedical is a company focused on developing high-quality cryogenic storage and transport solutions for biomedical and animal husbandry sectors, ensuring optimal sample preservation and operational compliance. Founded in 2020, IC Biomedical operates out of Indianapolis, US, and specializes in creating cryogenic storage equipment. The company has not reported any significant pivots or changes in business operations since its inception. Jim Fry serves as the CEO, bringing experience in the biomedical field to the company.

IC Biomedical specializes in the production of high-quality cryogenic storage and transport equipment, catering primarily to the biomedical and animal husbandry sectors. Their core offerings include cryogenic storage vessels, high-capacity cryostorage freezers, and laboratory systems designed for optimal sample preservation. Noteworthy solutions like the Revolution Series Cryogenic Freezers and the Revolution-Q with CELLTRIO Robostar Automation Technology exemplify IC Biomedical's innovation, enhancing operational efficiency in environments requiring meticulous temperature control. Their products serve a diverse clientele, including biomedical researchers, biobanks, pharmaceutical companies, and animal breeding programs, primarily in North America, Europe, and Asia.

All products are produced in their ISO 13485:2016-certified facility in Cartersville, Georgia, ensuring compliance with rigorous quality standards essential for medical applications. The revenue structure of IC Biomedical is built around direct sales of its proprietary cryogenic equipment to various sectors, particularly in biomedical research and animal husbandry. Transactions typically occur through B2B arrangements with hospitals, research institutions, and biotechnology firms, where clients purchase products or enter into service agreements for ongoing support. Their flagship products, including the high-capacity Revolution Series Freezers and specialized vapor shippers for biomaterials, form the backbone of revenue generation in regulated environments.

Pricing reflects the advanced engineering and technology integrated into these products, with customized solutions available to meet specific client needs. Through strategic partnerships and direct sales, IC Biomedical maintains a robust transactional framework to support its growth within the cryogenic equipment market.